Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma - PubMed (original) (raw)

. 1994 Jun 15;54(12):3107-10.

Affiliations

PMID: 8205525

Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma

N Nishida et al. Cancer Res. 1994.

Abstract

We analyzed the genetic alterations of the cyclin D1 and INT-2 genes in hepatocellular carcinomas (HCCs) from 45 patients. Among these, expression of the cyclin D1 mRNA was also analyzed in 18 of them by Northern blotting. The cyclin D1 gene was amplified 3-16 fold in five HCCs (11%); among these, the INT-2 gene was also amplified 2-10 fold in four HCCs. We analyzed the mRNA of cyclin D1 in four HCCs with gene amplifications, and 6-10 fold overexpressions were detected in all of them. Because the cyclin D1 gene was amplified in patients at an advanced stage of HCC with rapid tumor growth, it appeared to be associated with the aggressive behavior of tumors. Studies on loss of heterozygosity on chromosome 13q, where the retinoblastoma (RB) gene is located, indicated that all HCCs with an amplified cyclin D1 gene retained heterozygosity on chromosome 13q. These results suggest that amplification and overexpression of the cyclin D1 gene result in the rapid growth of a subset of HCC, even though the function of the RB gene is retained.

PubMed Disclaimer

Cited by

5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway.
Tonon F, Cemazar M, Kamensek U, Zennaro C, Pozzato G, Caserta S, Ascione F, Grassi M, Guido S, Ferrari C, Cansolino L, Trotta F, Kuzmanov BG, Forte G, Martino F, Perrone F, Bomben R, Gattei V, Elvassore N, Murano E, Truong NH, Olson M, Farra R, Grassi G, Dapas B. Tonon F, et al. Cancers (Basel). 2022 Mar 23;14(7):1630. doi: 10.3390/cancers14071630. Cancers (Basel). 2022. PMID: 35406401 Free PMC article.
Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma.
Saelee P, Wongkham S, Bhudhisawasdi V, Sripa B, Chariyalertsak S, Petmitr S. Saelee P, et al. J Cancer Res Clin Oncol. 2008 Oct;134(10):1135-41. doi: 10.1007/s00432-008-0379-1. Epub 2008 Apr 2. J Cancer Res Clin Oncol. 2008. PMID: 18386060
Molecular biology of adenoid cystic carcinoma.
Liu J, Shao C, Tan ML, Mu D, Ferris RL, Ha PK. Liu J, et al. Head Neck. 2012 Nov;34(11):1665-77. doi: 10.1002/hed.21849. Epub 2011 Oct 17. Head Neck. 2012. PMID: 22006498 Free PMC article. Review.
Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma in China: a SELDI-TOF-MS study.
Zhang J, Li D, Zheng Y, Cui Y, Feng K, Zhou J, Wu J. Zhang J, et al. Int J Clin Exp Pathol. 2008 Jan 1;1(4):352-61. Int J Clin Exp Pathol. 2008. PMID: 18787613 Free PMC article.
Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways.
Seifert L, Deutsch M, Alothman S, Alqunaibit D, Werba G, Pansari M, Pergamo M, Ochi A, Torres-Hernandez A, Levie E, Tippens D, Greco SH, Tiwari S, Ly NNG, Eisenthal A, van Heerden E, Avanzi A, Barilla R, Zambirinis CP, Rendon M, Daley D, Pachter HL, Hajdu C, Miller G. Seifert L, et al. Cell Rep. 2015 Dec 1;13(9):1909-1921. doi: 10.1016/j.celrep.2015.10.058. Epub 2015 Nov 19. Cell Rep. 2015. PMID: 26655905 Free PMC article.

Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma - PubMed (original) (raw)